Label Changes for:
Omontys (Peginesatide) Injection
Changes have been made to the CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – December 2012
- Serious allergic reactions to OMONTYS which may include anaphylaxis